BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 33771397)

  • 1. Outcomes of sentinel lymph node mapping for patients with FIGO stage I endometrioid endometrial carcinoma.
    Nasioudis D; Byrne M; Ko EM; Giuntoli RL; Haggerty AF; Cory L; Kim SH; Morgan MA; Latif NA
    Gynecol Oncol; 2021 Jun; 161(3):705-709. PubMed ID: 33771397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion.
    Zahl Eriksson AG; Ducie J; Ali N; McGree ME; Weaver AL; Bogani G; Cliby WA; Dowdy SC; Bakkum-Gamez JN; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2016 Mar; 140(3):394-9. PubMed ID: 26747778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radical hysterectomy is not associated with a survival benefit for patients with stage II endometrial carcinoma.
    Nasioudis D; Sakamuri S; Ko EM; Haggerty AF; Giuntoli RL; Burger RA; Morgan MA; Latif NA
    Gynecol Oncol; 2020 May; 157(2):335-339. PubMed ID: 32089334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of sentinel lymph node sampling versus traditional lymphadenectomy on the survival of patients with stage IIIC endometrial cancer.
    Nasioudis D; Byrne M; Ko EM; Giuntoli Ii RL; Haggerty AF; Cory L; Kim SH; Morgan MA; Latif NA
    Int J Gynecol Cancer; 2021 Jun; 31(6):840-845. PubMed ID: 33853879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of prognostic value of lymphovascular space invasion in patients with endometrial cancer and negative sentinel lymph nodes.
    Matanes E; Eisenberg N; Lau S; Salvador S; Ferenczy A; Pelmus M; Gotlieb WH; Kogan L
    Gynecol Oncol; 2021 Aug; 162(2):256-261. PubMed ID: 34119364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of aortic lymph node metastasis in endometrial cancer: Potential implications for selective aortic lymph node assessment.
    Cosgrove CM; Cohn DE; Rhoades J; Felix AS
    Gynecol Oncol; 2019 Jun; 153(3):505-510. PubMed ID: 30935714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of adjuvant therapy in stage IIIC2 endometrial cancer.
    Bogani G; Cappuccio S; Casarin J; Narasimhulu DMM; Cilby WA; Glaser GE; Weaver AL; McGree ME; Keeney GL; Weroha J; Petersen IA; Mariani A
    Int J Gynecol Cancer; 2020 Aug; 30(8):1169-1176. PubMed ID: 32646864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of adjuvant chemotherapy in patients with FIGO stage IB grade 3 endometrial endometrioid adenocarcinoma treated with surgery and post-operative radiotherapy.
    Reshko LB; Gaskins JT; Dryden SM; Metzinger DS; Todd SL; Eldredge-Hindy HB; Silva SR
    Int J Gynecol Cancer; 2021 May; 31(5):694-701. PubMed ID: 33741653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter study comparing oncologic outcomes between two nodal assessment methods in patients with deeply invasive endometrioid endometrial carcinoma: A sentinel lymph node algorithm versus a comprehensive pelvic and paraaortic lymphadenectomy.
    Schlappe BA; Weaver AL; Ducie JA; Eriksson AGZ; Dowdy SC; Cliby WA; Glaser GE; Soslow RA; Alektiar KM; Makker V; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2018 Nov; 151(2):235-242. PubMed ID: 30177461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a benefit of performing an omentectomy for clinical stage I high-grade endometrial carcinoma?
    Nasioudis D; Heyward Q; Gysler S; Giuntoli RL; Cory L; Kim S; Morgan MA; Haggerty AF; Ko EM; Latif NA
    Surg Oncol; 2021 Jun; 37():101534. PubMed ID: 33667893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.
    Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH
    Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of minimally invasive surgery for patients with endometrial carcinoma involving the cervix.
    Nasioudis D; Frey MK; Chapman-Davis E; Caputo TA; Holcomb K
    Int J Gynecol Cancer; 2020 May; 30(5):619-625. PubMed ID: 32276935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of lymphadenectomy and prevalence of lymph node metastasis in clinically-apparent stage I endometrioid and mucinous ovarian carcinoma.
    Nasioudis D; Chapman-Davis E; Witkin SS; Holcomb K
    Gynecol Oncol; 2017 Feb; 144(2):414-419. PubMed ID: 27908528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective multicenter international single-arm observational study on the oncological safety of the sentinel lymph node algorithm in stage I intermediate-risk endometrial cancer (SELECT, SEntinel Lymph node Endometrial Cancer Trial).
    Grassi T; Mariani A; Cibula D; Soliman PT; Suman VJ; Weaver AL; Pedra Nobre S; Weigelt B; Glaser GE; Cappuccio S; Abu-Rustum NR
    Int J Gynecol Cancer; 2020 Oct; 30(10):1627-1632. PubMed ID: 32699021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of pelvic lymph node metastasis using modern FIGO staging and sentinel lymph node mapping with ultrastaging in surgically staged patients with endometrioid and serous endometrial carcinoma.
    Mueller JJ; Pedra Nobre S; Braxton K; Alektiar KM; Leitao MM; Aghajanian C; Ellenson LH; Abu-Rustum NR
    Gynecol Oncol; 2020 Jun; 157(3):619-623. PubMed ID: 32247604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node staging in grade 1-2 endometrioid ovarian carcinoma apparently confined to the ovary: Is it worth?
    Bizzarri N; Imterat M; Fruscio R; Giannarelli D; Perrone AM; Mancari R; Traut A; Rosati A; du Bois A; Ferrari D; De Iaco P; Ergasti R; Ataseven B; Bianchi T; Di Stanislao M; Perri MT; Heitz F; Concin N; Fanfani F; Vizza E; Scambia G; Harter P; Fagotti A
    Eur J Cancer; 2023 Dec; 195():113398. PubMed ID: 37890354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overall survival after surgical staging by lymph node dissection versus sentinel lymph node biopsy in endometrial cancer: a national cancer database study.
    Garzon S; Mariani A; Day CN; Habermann EB; Langstraat C; Glaser G; Kumar A; Casarin J; Uccella S; Ghezzi F; Larish A
    Int J Gynecol Cancer; 2022 Jan; 32(1):28-40. PubMed ID: 34750199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of surgical approach on prevalence of positive peritoneal cytology and lymph-vascular invasion in patients with early-stage endometrial carcinoma: a National Cancer Database study.
    Nasioudis D; Ko EM; Cory L; Latif N
    Int J Gynecol Cancer; 2021 Jul; 31(7):1001-1006. PubMed ID: 33853880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is lymphadenectomy a prognostic marker in endometrioid adenocarcinoma of the human endometrium?
    Bassarak N; Blankenstein T; Brüning A; Dian D; Bergauer F; Friese K; Mylonas I
    BMC Cancer; 2010 May; 10():224. PubMed ID: 20492712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of External Beam Radiation Therapy to Adjuvant Chemotherapy for Patients With Stage IIIC Uterine Endometrioid Carcinoma: Utilization and Outcomes.
    Nasioudis D; Taunk NK; Ko EM; Haggerty AF; Cory L; Giuntoli RL; Kim SH; Latif NA
    Am J Clin Oncol; 2022 Sep; 45(9):373-378. PubMed ID: 35926158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.